In addition, based on a population-based prospective cohort study, statin treatment was reported to suppress the production of proinflammatory cytokines, such as IL-6 and IL-8, in hypercholesterolemic patients and to reduce the risk of developing HCC in a dose-dependent manner37,38. This evidence concerns the gene CXCL8 and hepatocellular carcinoma.